Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pericardium-covered stents

This article was originally published in The Gray Sheet

Executive Summary

FDA grants humanitarian use device designation to ITGI Medical's Over and Under and AneuGraft equine pericardium-covered stainless steel stents for treatment of perforations and dissections of native coronary arteries and saphenous vein grafts. The pericardium creates a barrier between the blood vessel wall and the lumen, the Israeli company explains. The HUD designation is the first step toward humanitarian device exemption approval. FDA grants HDE approvals for devices that treat a disease affecting 4,000 or fewer patients in the U.S. each year if the sponsor can demonstrate safety and probable benefit. The devices are already available in Europe, Israel and Latin America
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT027400

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel